Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1218 Articles

Lee Jackson | Feb 29, 2016 at 10:45 AM EST

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…

Jon C. Ogg | Feb 25, 2016 at 7:25 AM EST

The 18 Companies That Will Buy Back the Most Stock in 2016

It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most…

Paul Ausick | Feb 5, 2016 at 4:01 PM EST

The 4 Stocks That Tanked the Dow on Friday

February 5, 2016: Markets opened lower on Friday following a lower-than-expected report on nonfarm payrolls. There appears to be some…

Chris Lange | Jan 26, 2016 at 9:05 AM EST

Johnson & Johnson Kicks Off 2016 With Solid Earnings and Guidance

Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jan 25, 2016 at 12:40 PM EST

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.

Chris Lange | Jan 24, 2016 at 10:15 AM EST

Top DJIA Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that…

Jon C. Ogg | Jan 20, 2016 at 7:50 AM EST

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if…

Chris Lange | Jan 19, 2016 at 11:20 AM EST

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

Johnson & Johnson is looking to save some money over the next few years and as a result it is…

Chris Lange | Jan 6, 2016 at 10:35 AM EST

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…

Douglas A. McIntyre | Oct 27, 2015 at 11:00 AM EDT

The 10 Most Profitable Companies in the World

ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not…

Chris Lange | Oct 23, 2015 at 4:09 PM EDT

Janssen Secures Approval From FDA on New LPS and LMS Drug

ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with…

Paul Ausick | Oct 15, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the Dow on Thursday

ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech…

Paul Ausick | Oct 13, 2015 at 8:05 AM EDT

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

Johnson & Johnson reported mixed third-quarter 2015 results before markets opened Tuesday morning.

Chris Lange | Oct 12, 2015 at 1:55 PM EDT

What to Expect From Johnson & Johnson Earnings

Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 11, 2015 at 9:25 AM EDT

Top Dow Earnings in the Coming Week

24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting…

1 … 42 43 44 45 46 … 82

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 18 Companies That Will Buy Back the Most Stock in 2016

The 4 Stocks That Tanked the Dow on Friday

Johnson & Johnson Kicks Off 2016 With Solid Earnings and Guidance

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings for the Week Ahead

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

The 10 Most Profitable Companies in the World

Janssen Secures Approval From FDA on New LPS and LMS Drug

The 4 Stocks That Dominated the Dow on Thursday

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

What to Expect From Johnson & Johnson Earnings

Top Dow Earnings in the Coming Week

Why the Pay Off the Mortgage Rule Can Cost High-Income Households Six Figures

Caterpillar Soars But Analysts Remain Cautious

DraftKings: Risk-Reward Remains Attractive for Patient Investors

Why the Pay Off the Mortgage Rule Can Cost High-Income Households Six Figures

The Portfolio That Quietly Pays For Your Midlife Crisis Car

Why the Pay Off the Mortgage Rule Can Cost High-Income Households Six Figures

Caterpillar Soars But Analysts Remain Cautious

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 18 Companies That Will Buy Back the Most Stock in 2016

The 4 Stocks That Tanked the Dow on Friday

Johnson & Johnson Kicks Off 2016 With Solid Earnings and Guidance

What to Look for in Johnson & Johnson Earnings

Top DJIA Earnings for the Week Ahead

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

The 10 Most Profitable Companies in the World

Janssen Secures Approval From FDA on New LPS and LMS Drug

The 4 Stocks That Dominated the Dow on Thursday

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

What to Expect From Johnson & Johnson Earnings

Top Dow Earnings in the Coming Week

Why the Pay Off the Mortgage Rule Can Cost High-Income Households Six Figures

Caterpillar Soars But Analysts Remain Cautious

DraftKings: Risk-Reward Remains Attractive for Patient Investors

Featured Reads

Why the Pay Off the Mortgage Rule Can Cost High-Income Households Six Figures

The Portfolio That Quietly Pays For Your Midlife Crisis Car